COST-UTILITY ANALYSIS OF INSULIN GLARGINE 300 U/ML VERSUS INSULIN GLARGINE 100 U/ML AND INSULIN DEGLUDEC 100 U/ML IN PATIENTS WITH TYPE 2 DIABETES MELLITUS IN CROATIA

被引：0
|
作者：
Bogdanovic, M. [1 ]
Fournier, M. [2 ]
Vitezic, D. [3 ,4 ]
机构：
[1] Sanofi Aventis Doo, Belgrade, Serbia
[2] Sanofi, Chilly Mazarin, France
[3] Univ Rijeka, Sch Med, Rijeka, Croatia
[4] Univ Hosp Ctr Rijeka, Rijeka, Croatia
来源：
VALUE IN HEALTH | 2018年 / 21卷
关键词：
D O I：
10.1016/j.jval.2018.09.784
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PDB79
引用
收藏
页码：S131 / S132
页数：3
相关论文
共 50 条
  • [1] COST-UTILITY ANALYSIS OF INSULIN GLARGINE 300 U/ML VERSUS INSULIN GLARGINE 100 U/ML AND INSULIN DEGLUDEC 100 U/ML IN PATIENTS WITH TYPE 2 DIABETES MELLITUS IN BULGARIA
    Bogdanovic, M.
    Mihajlovic, J.
    Fournier, M.
    [J]. VALUE IN HEALTH, 2018, 21 : S133 - S133
  • [2] COST-UTILITY EVALUATION OF INSULIN GLARGINE (300 U/ML) VERSUS INSULIN GLARGINE (100 U/ML) AND INSULIN DEGLUDEC (100 U/ML) IN PATIENTS WITH TYPE 2 DIABETES MELLITUS IN SERBIA
    Mihajlovic, J.
    Bogdanovic, M.
    Foumier, M.
    [J]. VALUE IN HEALTH, 2017, 20 (09) : A481 - A481
  • [3] Glycaemic variability and risk for hypoglycaemia on insulin glargine 300 U/ml versus insulin glargine 100 U/ml in people with type 2 diabetes
    Kovatchev, B.
    Meng, Z.
    Breton, M.
    Leroy, B.
    Cali, A.
    Perfetti, R.
    [J]. DIABETOLOGIA, 2017, 60 : S36 - S37
  • [4] The efficacy of switching from Insulin Glargine 100 U/mL (Gla-100) to Insulin Glargine 300 U/mL (Gla-300) in patients with type 2 diabetes mellitus
    Yang, K. -H.
    Tseng, C. -T.
    Chen, L. -C.
    Chen, P. -C.
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2019, 41 (01) : 310 - 310
  • [5] Low Blood Glucose Index and Hypoglycaemia Risk: Insulin Glargine 300 U/mL Versus Insulin Glargine 100 U/mL in Type 2 Diabetes
    Kovatchev, Boris
    Meng, Zhaoling
    Cali, Anna M. G.
    Perfetti, Riccardo
    Breton, Marc D.
    [J]. DIABETES THERAPY, 2020, 11 (06) : 1293 - 1302
  • [6] Low Blood Glucose Index and Hypoglycaemia Risk: Insulin Glargine 300 U/mL Versus Insulin Glargine 100 U/mL in Type 2 Diabetes
    Boris Kovatchev
    Zhaoling Meng
    Anna M. G. Cali
    Riccardo Perfetti
    Marc D. Breton
    [J]. Diabetes Therapy, 2020, 11 : 1293 - 1302
  • [7] In Silico Head-to-Head Comparison of Insulin Glargine 300 U/mL and Insulin Degludec 100 U/mL in Type 1 Diabetes
    Schiavon, Michele
    Visentin, Roberto
    Giegerich, Clemens
    Sieber, Jochen
    Dalla Man, Chiara
    Cobelli, Claudio
    Klabunde, Thomas
    [J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2020, 22 (08) : 553 - 561
  • [8] Insulin glargine 300 U/ml versus Insulin degludec 100 U/ml Direct Comparison of long-acting Insulins
    Stiefelhagen, Peter
    [J]. AUSTRIAN JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM, 2019, 12 (01): : 38 - 38
  • [9] Comparison of pharmacodynamics between insulin glargine 100 U/mL and insulin glargine 300 U/mL in healthy cats
    Saini, N. K.
    Wasik, B.
    Pires, J.
    Leale, D. M.
    Quach, N.
    Culp, W. T. N.
    Samms, R. J.
    Johnson, A. E.
    Owens, J. G.
    Gilor, C.
    [J]. DOMESTIC ANIMAL ENDOCRINOLOGY, 2021, 75
  • [10] Investigational new insulin glargine 300 U/ml has the same metabolism as insulin glargine 100 U/ml
    Steinstraesser, A.
    Schmidt, R.
    Bergmann, K.
    Dahmen, R.
    Becker, R. H. A.
    [J]. DIABETES OBESITY & METABOLISM, 2014, 16 (09): : 873 - 876
12345